[go: up one dir, main page]

DK155690D0 - NEW PEPTIDES - Google Patents

NEW PEPTIDES

Info

Publication number
DK155690D0
DK155690D0 DK155690A DK155690A DK155690D0 DK 155690 D0 DK155690 D0 DK 155690D0 DK 155690 A DK155690 A DK 155690A DK 155690 A DK155690 A DK 155690A DK 155690 D0 DK155690 D0 DK 155690D0
Authority
DK
Denmark
Prior art keywords
new peptides
peptides
new
Prior art date
Application number
DK155690A
Other languages
Danish (da)
Inventor
Jan Markussen
Liselotte Langkjaer
Kjeld Norris
Leo Boye Snel
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK155690A priority Critical patent/DK155690D0/en
Publication of DK155690D0 publication Critical patent/DK155690D0/en
Priority to EP91912264A priority patent/EP0536245A1/en
Priority to AU80543/91A priority patent/AU8054391A/en
Priority to PCT/DK1991/000167 priority patent/WO1992000321A1/en
Priority to JP3511335A priority patent/JPH05508406A/en
Priority to IL98596A priority patent/IL98596A0/en
Priority to ZA914830A priority patent/ZA914830B/en
Priority to NZ238718A priority patent/NZ238718A/en
Priority to IE224791A priority patent/IE912247A1/en
Priority to PT98124A priority patent/PT98124A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK155690A 1990-06-28 1990-06-28 NEW PEPTIDES DK155690D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES
EP91912264A EP0536245A1 (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
AU80543/91A AU8054391A (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
PCT/DK1991/000167 WO1992000321A1 (en) 1990-06-28 1991-06-21 Novel, protracted insulin analogues
JP3511335A JPH05508406A (en) 1990-06-28 1991-06-21 Novel protected insulin analogs
IL98596A IL98596A0 (en) 1990-06-28 1991-06-24 Insulin analogues having prolonged action,their preparation and injectable solutions containing them
ZA914830A ZA914830B (en) 1990-06-28 1991-06-24 Novel,protracted insulin analogues
NZ238718A NZ238718A (en) 1990-06-28 1991-06-26 Insulin analogue and its preparation
IE224791A IE912247A1 (en) 1990-06-28 1991-06-27 Novel, protracted insulin analogues
PT98124A PT98124A (en) 1990-06-28 1991-06-27 PROCESS FOR THE PREPARATION OF NEW PROLONGED ACID INSULIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES

Publications (1)

Publication Number Publication Date
DK155690D0 true DK155690D0 (en) 1990-06-28

Family

ID=8106031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155690A DK155690D0 (en) 1990-06-28 1990-06-28 NEW PEPTIDES

Country Status (10)

Country Link
EP (1) EP0536245A1 (en)
JP (1) JPH05508406A (en)
AU (1) AU8054391A (en)
DK (1) DK155690D0 (en)
IE (1) IE912247A1 (en)
IL (1) IL98596A0 (en)
NZ (1) NZ238718A (en)
PT (1) PT98124A (en)
WO (1) WO1992000321A1 (en)
ZA (1) ZA914830B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646396A (en) * 2018-12-29 2019-04-19 江苏万邦医药科技有限公司 A kind of stable insulin analog injection and preparation method thereof

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT792290E (en) * 1993-09-17 2002-01-30 Novo Nordisk As INSULINA ACILADA
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
JP3872105B2 (en) * 1995-03-17 2007-01-24 ノボ ノルディスク アクティーゼルスカブ Insulin derivative
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
DE19726167B4 (en) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, process for its preparation and pharmaceutical preparation containing it
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
AU2005205867A1 (en) 2004-01-21 2005-08-04 Novo Nordisk Health Care Ag Transglutaminase mediated conjugation of peptides
EP2049149B1 (en) 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
DK2074141T3 (en) 2006-09-22 2016-11-28 Novo Nordisk As The protease resistant insulin analogues.
ES2563038T3 (en) 2007-04-30 2016-03-10 Novo Nordisk A/S Method for drying a protein composition, a dry protein composition and a pharmaceutical composition comprising the dry protein
BRPI0907371A2 (en) 2008-01-09 2015-11-24 Sanofi Aventis Deutschland insulin derivatives with a very delayed time-action profile
JP5762001B2 (en) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス Protease stabilized insulin analogue
RU2571857C2 (en) 2008-03-18 2015-12-20 Ново Нордиск А/С Acylated insulin analogues stabilised with respect to proteases
PL2349324T3 (en) 2008-10-17 2018-02-28 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a glp-1 agonist
DE102008053048A1 (en) 2008-10-24 2010-04-29 Sanofi-Aventis Deutschland Gmbh Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist
DE102009038210A1 (en) 2009-08-20 2011-03-03 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1 agonist
DE102008051834A1 (en) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Drug, useful e.g. for treating diabetes, preferably type-I or II and for controlling fasting, postprandial and/or postabsorptive plasma glucose concentration, comprises insulin and glucagon-like peptide-1 agonist
DE102008064270A1 (en) * 2008-12-20 2010-07-01 Voith Patent Gmbh Flotation method for removing contaminants from aqueous fibrous material suspension by gas bubbles, involves supplying stream of fibrous material suspension along interference body after supplying stream of gas
WO2011003823A1 (en) 2009-07-06 2011-01-13 Sanofi-Aventis Deutschland Gmbh Slow-acting insulin preparations
MY159865A (en) 2009-07-06 2017-02-15 Sanofi Aventis Deutschland Aqueous insulin preparations containing methionine
EP2451472A1 (en) * 2009-07-06 2012-05-16 Sanofi-Aventis Deutschland GmbH Heat- and vibration-stable insulin preparations
AU2010277559B2 (en) 2009-07-31 2016-08-11 Sanofi-Aventis Deutschland Gmbh Prodrugs comprising an insulin linker conjugate
MX2012001141A (en) 2009-07-31 2012-03-29 Sanofi Aventis Deutschland Long acting insulin composition.
PL2498802T3 (en) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2011161083A1 (en) * 2010-06-23 2011-12-29 Novo Nordisk A/S Human insulin containing additional disulfide bonds
WO2011161124A1 (en) * 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
AU2011269000C1 (en) 2010-06-23 2015-10-08 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
PL2611458T3 (en) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
EP2438930A1 (en) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrugs comprising an exendin linker conjugate
CN103533952B (en) 2011-03-15 2017-02-15 诺沃—诺迪斯克有限公司 Human insulin analogues and derivatives comprising cysteine substitutions
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CA2846413C (en) 2011-08-29 2021-11-02 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP2836508B1 (en) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulin formulations
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
SI2854841T1 (en) 2012-06-04 2017-06-30 Diamedica Inc. Human tissue kallikrein 1 glycosylation isoforms
CN104994864B (en) 2012-12-19 2018-05-29 沃克哈特有限公司 Include actrapid monotard or the stable aqueous composition of its analog or derivative
RU2015130613A (en) 2012-12-26 2017-01-31 Вокхардт Лимитед PHARMACEUTICAL COMPOSITION
TWI780236B (en) 2013-02-04 2022-10-11 法商賽諾菲公司 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
WO2015044922A1 (en) 2013-09-30 2015-04-02 Wockhardt Limited Pharmaceutical composition
MX366636B (en) 2013-10-07 2019-07-17 Novo Nordisk As Novel derivative of an insulin analogue.
JP6735674B2 (en) 2014-01-09 2020-08-05 サノフイＳａｎｏｆｉ Stabilized pharmaceutical formulation of insulin aspart
SG11201604710XA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
CN111658604A (en) 2014-01-09 2020-09-15 赛诺菲 Stabilized glycerol-free pharmaceutical formulations of insulin analogues and/or insulin derivatives
WO2016001862A1 (en) 2014-07-04 2016-01-07 Wockhardt Limited Extended release formulations of insulins
LT3229828T (en) 2014-12-12 2023-06-12 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
DK3554534T3 (en) 2016-12-16 2021-08-23 Novo Nordisk As PHARMACEUTICAL COMPOSITION INCLUDING INSULIN
KR20190122706A (en) 2017-03-09 2019-10-30 다이어메디카 인코포레이티드 Dosage form of tissue kallikrein 1
CA3071686A1 (en) 2017-08-17 2019-02-21 Novo Nordisk A/S Novel acylated insulin analogues and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2536040A1 (en) * 1975-08-13 1977-02-24 Hoechst Ag Prolonged action insulin analogues - with A1-glycine replaced by D-alanine or D-serine
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (en) * 1988-05-11 1988-05-11 Novo Industri As NEW PEPTIDES
KR910700262A (en) * 1988-12-23 1991-03-14 안네 제케르 Human insulin analogues

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109646396A (en) * 2018-12-29 2019-04-19 江苏万邦医药科技有限公司 A kind of stable insulin analog injection and preparation method thereof

Also Published As

Publication number Publication date
ZA914830B (en) 1992-03-25
IL98596A0 (en) 1992-07-15
PT98124A (en) 1992-04-30
IE912247A1 (en) 1992-01-01
EP0536245A1 (en) 1993-04-14
WO1992000321A1 (en) 1992-01-09
JPH05508406A (en) 1993-11-25
NZ238718A (en) 1992-06-25
AU8054391A (en) 1992-01-23

Similar Documents

Publication Publication Date Title
DK155690D0 (en) NEW PEPTIDES
DK257988D0 (en) NEW PEPTIDES
NO972494L (en) Novel hedgehog-derived polypeptides
NO940669D0 (en) Novel isosteric peptides
FI912086A7 (en) Polypeptides
NO942066L (en) peptide
NO303016B1 (en) New connections
DK111489D0 (en) PEPTIDES
NO952650D0 (en) New peptides
NO930156D0 (en) NEW OKSAZOLYL DERIVATIVES
FI941758L (en) Recombitope peptides
DK158390D0 (en) NEW PEPTIDES
FI905741A7 (en) Peptides
DK616889A (en) NEW ALFA-CYANO-BETA-OXOPROPIONAMIDES
NO922243L (en) NEW CEFEM CONNECTIONS
FI911351A7 (en) New 8-sulfamylmethylene-2-aminotetralins
MA22717A1 (en) HEMOREGULATORY PEPTIDES
NO924900D0 (en) NEW TIAZOLS
NO942051D0 (en) New thiosemicarbazontions
DK66991D0 (en) NEW PEPTIDES
DK67091D0 (en) NEW PEPTIDES
NO940633D0 (en) New connections
DK312488D0 (en) NEW PEPTIDES
DK245190D0 (en) NEW CONNECTIONS
DK0454580T3 (en) New noirimycin derivatives

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed